chr19-7214271-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000208.4(INSR):c.653-29634G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.563 in 152,008 control chromosomes in the GnomAD database, including 24,232 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.56   (  24232   hom.,  cov: 31) 
Consequence
 INSR
NM_000208.4 intron
NM_000208.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -3.09  
Publications
16 publications found 
Genes affected
 INSR  (HGNC:6091):  (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015] 
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.582  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.653-29634G>A | intron_variant | Intron 2 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3 | c.653-29634G>A | intron_variant | Intron 2 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3 | c.653-29634G>A | intron_variant | Intron 2 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4 | c.653-29634G>A | intron_variant | Intron 2 of 20 | XP_011526291.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000302850.10 | c.653-29634G>A | intron_variant | Intron 2 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9 | c.653-29634G>A | intron_variant | Intron 2 of 20 | 1 | ENSP00000342838.4 | ||||
| INSR | ENST00000598216.1 | n.628-29634G>A | intron_variant | Intron 2 of 9 | 1 | 
Frequencies
GnomAD3 genomes  0.563  AC: 85566AN: 151890Hom.:  24219  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
85566
AN: 
151890
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.563  AC: 85613AN: 152008Hom.:  24232  Cov.: 31 AF XY:  0.560  AC XY: 41632AN XY: 74286 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
85613
AN: 
152008
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
41632
AN XY: 
74286
show subpopulations 
African (AFR) 
 AF: 
AC: 
23224
AN: 
41456
American (AMR) 
 AF: 
AC: 
8168
AN: 
15268
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2020
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
2210
AN: 
5162
South Asian (SAS) 
 AF: 
AC: 
2614
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
5743
AN: 
10574
Middle Eastern (MID) 
 AF: 
AC: 
163
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
39879
AN: 
67948
Other (OTH) 
 AF: 
AC: 
1183
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1915 
 3830 
 5744 
 7659 
 9574 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 744 
 1488 
 2232 
 2976 
 3720 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1647
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.